Teens Seek 'Skinny' Drugs Amidst Obesity Crisis

Childhood obesity rates have dramatically increased, with approximately 22.2 per cent of 10 to 11-year-olds in England now living with obesity as of recent NHS data. This rise has led to a significant increase in the prescription of GLP-1 weight-loss drugs for young people. In the US, a study indicated a 310-fold rise in GLP-1 prescriptions for children aged 8-11 with obesity between 2019 and 2026.

NHS England's specialist clinics have treated nearly 6,500 children under 17 since 2021, with some as young as four receiving treatment, including drugs like Wegovy for those 12 and older. However, concerns are mounting about the rise in disordered eating, with hospital admissions for eating disorders among children and young people increasing six-fold between 2012 and 2022.

Teenagers are increasingly influenced by celebrity culture promoting extreme thinness, with some researching weight-loss drugs to achieve a 'super-skinny' look. This aspirational thin culture is impacting vulnerable teenagers, as evidenced by a rise in eating disorders among both girls and boys. Experts worry that GLP-1s may not address underlying issues and could contribute to a culture of seeking quick fixes.

The article also highlights the pervasive marketing of unhealthy foods, with food manufacturers spending significantly on digital advertising. Despite advertising restrictions, companies shift budgets to unregulated channels. This environment makes maintaining healthy habits challenging, particularly for families in food deserts or during a cost of living crisis, suggesting the obesity crisis is also a social issue.